Charge-reversal Nanoparticles: Novel Targeted Drug Delivery Carriers

Xinli Chen, Lisha Liu, Chen Jiang

Acta Pharm Sin B. 2016 Jul;6(4):261-7.

PMID: 27471667

Abstract:

Spurred by significant progress in materials chemistry and drug delivery, charge-reversal nanocarriers are being developed to deliver anticancer formulations in spatial-, temporal- and dosage-controlled approaches. Charge-reversal nanoparticles can release their drug payload in response to specific stimuli that alter the charge on their surface. They can elude clearance from the circulation and be activated by protonation, enzymatic cleavage, or a molecular conformational change. In this review, we discuss the physiological basis for, and recent advances in the design of charge-reversal nanoparticles that are able to control drug biodistribution in response to specific stimuli, endogenous factors (changes in pH, redox gradients, or enzyme concentration) or exogenous factors (light or thermos-stimulation).

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
LS793889	(4-chlorocarbonylphenyl)boronic anhydride			Price
AP6274120	Diethylammonium bromide		6274-12-0	Price
LS74633	Polyethylenimine hydrochloride			Price
AP134874490	O-(2-Mercaptoethyl)-O′-methylpolyethylene glycol		134874-49-0	Price
LS775181	Poly(fluorescein isothiocyanate allylamine hydrochloride)			Price